Xplico was established in 2005 with the purpose to develop and market an easy-to-use and standardized tool for valuation of projects and portfolios in the life science industry. Xplico is today the market leader in valuation, supporting more than 100 life science companies in EU, US and Asia on a daily basis.

Currently, Xplico markets three solutions: 

  • Xplico Evaluator is an easy-to-use, flexible valuation tool with integrated risk assessment and powerful analysis features for the life science industry.
  • Xplico CapTable is an easy-to-use standardized Excel-based tool which is built and tailored to keeping accurate track of multiple ownership and exit scenarios.
  • Consulting services. We have extensive experience in valuation, forecasting and project/portfolio management and our team of consultants can evaluate your projects and/or company or support you during partnering negotiations.

  • News from the Xplico world